ARTICLE | Company News
Roche said it will terminate a 2013 deal to develop and commercialize diagnostics based on Pacific’s Single Molecule Real-Time (SMRT) technology. Roche will have no rights to the technology except for...
Roche said it will terminate a 2013 deal to develop and commercialize diagnostics based on Pacific’s Single Molecule Real-Time (SMRT) technology. Roche will have no rights to the technology except for...